vs

Side-by-side financial comparison of RETRACTABLE TECHNOLOGIES INC (RVP) and TECOGEN INC. (TGEN). Click either name above to swap in a different company.

RETRACTABLE TECHNOLOGIES INC is the larger business by last-quarter revenue ($9.4M vs $5.3M, roughly 1.8× TECOGEN INC.). RETRACTABLE TECHNOLOGIES INC runs the higher net margin — -24.9% vs -75.1%, a 50.2% gap on every dollar of revenue. On growth, RETRACTABLE TECHNOLOGIES INC posted the faster year-over-year revenue change (4.0% vs -12.5%). Over the past eight quarters, RETRACTABLE TECHNOLOGIES INC's revenue compounded faster (11.5% CAGR vs -7.3%).

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

RVP vs TGEN — Head-to-Head

Bigger by revenue
RVP
RVP
1.8× larger
RVP
$9.4M
$5.3M
TGEN
Growing faster (revenue YoY)
RVP
RVP
+16.5% gap
RVP
4.0%
-12.5%
TGEN
Higher net margin
RVP
RVP
50.2% more per $
RVP
-24.9%
-75.1%
TGEN
Faster 2-yr revenue CAGR
RVP
RVP
Annualised
RVP
11.5%
-7.3%
TGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RVP
RVP
TGEN
TGEN
Revenue
$9.4M
$5.3M
Net Profit
$-2.3M
$-4.0M
Gross Margin
-16.2%
36.8%
Operating Margin
-81.7%
-77.8%
Net Margin
-24.9%
-75.1%
Revenue YoY
4.0%
-12.5%
Net Profit YoY
-162.3%
-236.7%
EPS (diluted)
$-0.09
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RVP
RVP
TGEN
TGEN
Q4 25
$9.4M
$5.3M
Q3 25
$10.1M
$7.2M
Q2 25
$10.4M
$7.3M
Q1 25
$8.3M
$7.3M
Q4 24
$9.1M
$6.1M
Q3 24
$10.3M
$5.6M
Q2 24
$6.0M
$4.7M
Q1 24
$7.6M
$6.2M
Net Profit
RVP
RVP
TGEN
TGEN
Q4 25
$-2.3M
$-4.0M
Q3 25
$371.0K
$-2.1M
Q2 25
$-87.5K
$-1.5M
Q1 25
$-10.5M
$-659.9K
Q4 24
$3.8M
$-1.2M
Q3 24
$-1.9M
$-930.4K
Q2 24
$-14.2M
$-1.5M
Q1 24
$429.4K
$-1.1M
Gross Margin
RVP
RVP
TGEN
TGEN
Q4 25
-16.2%
36.8%
Q3 25
16.7%
30.4%
Q2 25
-1.0%
33.8%
Q1 25
-0.0%
44.3%
Q4 24
-27.5%
45.0%
Q3 24
-0.1%
44.1%
Q2 24
-7.0%
44.0%
Q1 24
25.0%
41.6%
Operating Margin
RVP
RVP
TGEN
TGEN
Q4 25
-81.7%
-77.8%
Q3 25
-36.2%
-29.2%
Q2 25
-49.1%
-19.4%
Q1 25
-56.4%
-8.2%
Q4 24
-79.6%
-18.7%
Q3 24
-49.6%
-15.5%
Q2 24
-95.6%
-31.2%
Q1 24
-39.3%
-17.0%
Net Margin
RVP
RVP
TGEN
TGEN
Q4 25
-24.9%
-75.1%
Q3 25
3.7%
-29.7%
Q2 25
-0.8%
-20.1%
Q1 25
-126.6%
-9.1%
Q4 24
41.6%
-19.5%
Q3 24
-18.6%
-16.5%
Q2 24
-234.9%
-32.5%
Q1 24
5.7%
-17.9%
EPS (diluted)
RVP
RVP
TGEN
TGEN
Q4 25
$-0.09
$-0.14
Q3 25
$0.01
$-0.07
Q2 25
$0.00
$-0.06
Q1 25
$-0.35
$-0.03
Q4 24
$0.14
$-0.05
Q3 24
$-0.07
$-0.04
Q2 24
$-0.48
$-0.06
Q1 24
$0.01
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RVP
RVP
TGEN
TGEN
Cash + ST InvestmentsLiquidity on hand
$2.6M
$12.4M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$74.4M
$21.6M
Total Assets
$142.6M
$37.0M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RVP
RVP
TGEN
TGEN
Q4 25
$2.6M
$12.4M
Q3 25
$3.4M
$15.3M
Q2 25
$3.0M
$1.6M
Q1 25
$3.4M
$4.1M
Q4 24
$4.2M
$5.4M
Q3 24
$3.9M
$1.3M
Q2 24
$6.9M
$841.9K
Q1 24
$10.0M
$1.5M
Total Debt
RVP
RVP
TGEN
TGEN
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RVP
RVP
TGEN
TGEN
Q4 25
$74.4M
$21.6M
Q3 25
$76.8M
$25.5M
Q2 25
$76.5M
$9.1M
Q1 25
$76.6M
$9.6M
Q4 24
$87.2M
$10.2M
Q3 24
$83.5M
$11.3M
Q2 24
$85.4M
$12.2M
Q1 24
$99.7M
$13.7M
Total Assets
RVP
RVP
TGEN
TGEN
Q4 25
$142.6M
$37.0M
Q3 25
$146.4M
$41.5M
Q2 25
$147.1M
$28.4M
Q1 25
$149.3M
$29.7M
Q4 24
$160.7M
$31.1M
Q3 24
$157.8M
$27.5M
Q2 24
$160.7M
$27.2M
Q1 24
$176.0M
$28.5M
Debt / Equity
RVP
RVP
TGEN
TGEN
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RVP
RVP
TGEN
TGEN
Operating Cash FlowLast quarter
$-596.5K
$-2.6M
Free Cash FlowOCF − Capex
$-2.6M
FCF MarginFCF / Revenue
-49.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-10.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RVP
RVP
TGEN
TGEN
Q4 25
$-596.5K
$-2.6M
Q3 25
$-1.3M
$-3.6M
Q2 25
$-3.7M
$-2.6M
Q1 25
$-1.5M
$-1.2M
Q4 24
$-1.1M
$4.2M
Q3 24
$-5.7M
$-207.3K
Q2 24
$-2.7M
$-157.9K
Q1 24
$-2.0M
$248.2K
Free Cash Flow
RVP
RVP
TGEN
TGEN
Q4 25
$-2.6M
Q3 25
$-1.3M
$-3.6M
Q2 25
$-4.1M
$-2.7M
Q1 25
$-1.6M
$-1.3M
Q4 24
$-1.4M
$4.0M
Q3 24
$-6.5M
$-489.6K
Q2 24
$-2.8M
$-609.6K
Q1 24
$-2.2M
$143.3K
FCF Margin
RVP
RVP
TGEN
TGEN
Q4 25
-49.3%
Q3 25
-13.4%
-50.6%
Q2 25
-38.9%
-37.7%
Q1 25
-18.8%
-17.9%
Q4 24
-15.5%
66.6%
Q3 24
-63.0%
-8.7%
Q2 24
-46.8%
-12.9%
Q1 24
-29.6%
2.3%
Capex Intensity
RVP
RVP
TGEN
TGEN
Q4 25
0.9%
Q3 25
0.9%
1.0%
Q2 25
3.2%
2.0%
Q1 25
1.0%
1.8%
Q4 24
3.3%
2.1%
Q3 24
7.7%
5.0%
Q2 24
2.0%
9.6%
Q1 24
3.0%
1.7%
Cash Conversion
RVP
RVP
TGEN
TGEN
Q4 25
Q3 25
-3.39×
Q2 25
Q1 25
Q4 24
-0.29×
Q3 24
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RVP
RVP

Segment breakdown not available.

TGEN
TGEN

Installation Services$4.5M84%
Products Segment$460.5K9%
Other$394.7K7%

Related Comparisons